Diabetes and obesity - Issue 38/2019
Reviews
75
Gut microbiome in children and risk of developing type 1 diabetes mellitus
Uboš Ambro, Anna Kamlárová, René Link, Ivana Lukáčová, Alojz Bo, Oliver Rácz
90
Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
Rudolf Chlup, Jana Zapletalová, Hana Zálešáková, Johana Kochtová, Richard Kaňa
98
103
Adipocytokines as possible etiopathogenetic mechanisms leading to a higher incidence of autoimmune thyroiditis in patients with type 2 diabetes mellitus
Štefan Sotak, Zbynek Schroner, Ivica Lazúrová, Marek Felš Ci, Darina Petrášová, Izabela Bertková, Miriam Mitníková, Jozefína Petrovičová
110
Management of arterial hypertension in persons with type 2 diabetes mellitus
Udovít Gašpar, Slavomíra Filipová
Clinical studies
115
118
121
Intensive glycemic compensation and prevention of chronic diabetic complications
Vladimír Uličiansky
Diabetes and obesity
2019 Issue 38
Most read in this issue
- Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
- Has everything really been discovered about SGLT2 inhibitors?
- Gut microbiome in children and risk of developing type 1 diabetes mellitus
- Management of arterial hypertension in persons with type 2 diabetes mellitus